Cyclo Therapeutics, Inc. Annual Return On Equity in % from 2013 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Cyclo Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2013 to 2023.
  • Cyclo Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was 10.3K %.
  • Cyclo Therapeutics, Inc. annual Return On Equity for 2023 was -4.51K %, a 2024% decline from 2022.
  • Cyclo Therapeutics, Inc. annual Return On Equity for 2022 was -212 %, a 1.66% increase from 2021.
  • Cyclo Therapeutics, Inc. annual Return On Equity for 2021 was -216 %, a 61.9% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -4.51K -4.29K -2024% Jan 1, 2023 Dec 31, 2023
2022 -212 +3.57 +1.66% Jan 1, 2022 Dec 31, 2022
2021 -216 +351 +61.9% Jan 1, 2021 Dec 31, 2021
2020 -567 -211 -59.5% Jan 1, 2020 Dec 31, 2020
2019 -355 +313 +46.9% Jan 1, 2019 Dec 31, 2019
2018 -669 -424 -174% Jan 1, 2018 Dec 31, 2018
2017 -245 -87.7 -55.9% Jan 1, 2017 Dec 31, 2017
2016 -157 -93.8 -149% Jan 1, 2016 Dec 31, 2016
2015 -63.1 -46.7 -285% Jan 1, 2015 Dec 31, 2015
2014 -16.4 -27.6 -245% Jan 1, 2014 Dec 31, 2014
2013 11.3 Jan 1, 2013 Dec 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.